Adaptimmune Therapeutics
ADAP
#8447
Rank
A$0.24 B
Marketcap
$0.97
Share price
0.82%
Change (1 day)
31.43%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: A$0.24 Billion

As of December 2024 Adaptimmune Therapeutics has a market cap of A$0.24 Billion. This makes Adaptimmune Therapeutics the world's 8447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2024

End of year Market Cap

Year Marketcap Change
2024A$0.24 B-6.47%
2023A$0.26 B-24.79%
2022A$0.35 B-56.5%
2021A$0.80 B-25.54%
2020A$1.08 B501.97%
2019A$0.18 B-78.88%
2018A$0.85 B6.48%
2017A$0.80 B101.56%
2016A$0.39 B-66.06%
2015A$1.17 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Adaptimmune Therapeutics was reported to be:

A$0.24 Billion
by Nasdaq info icon info icon
A$0.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$2.22 B 800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$63.64 M-74.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.32 B 434.72%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$15.18 B 6,042.07%๐Ÿ‡บ๐Ÿ‡ธ USA